Crossmark

Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles

Crossref DOI link: https://doi.org/10.1007/s00228-018-2468-7

Published Online: 2018-05-26

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lin, Jing

Han, Zhao

Wang, Chun

Yi, Xingyang

Chai, Zhenxiao

Zhou, Qiang

Huang, Ruyue
License Information

Text and Data Mining valid from 2018-05-26
More Information

Article History

Received: 20 February 2018

Accepted: 24 April 2018

First Online: 26 May 2018

Compliance with ethical standards

:

: The authors declare that they have no conflicts of interest.

: The study was approved by the Ethics Committees of the People’s Hospital of Deyang City and The Third Affiliated Hospital of Wenzhou Medical College, and is in accordance with the principles stated in the Declaration of Helsinki.

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below